BOYANOV & Co. Assists Sopharma in Completing Initial Stage of Strategic Pharmaceutical Portfolio Acquisition
Sopharma AD, Bulgaria’s leading pharmaceutical company, initiated an acquisition of a substantial portfolio comprising consumer healthcare and prescription products.
At the end of November 2024, Sopharma announced the completion of the due diligence procedures, marking the conclusion of the first stage of the acquisition. At this juncture, an amount of EUR 40 million was disbursed. The subsequent steps involve the transfer of marketing authorizations and trademarks, alongside the organization of trading activities in the respective markets.
BOYANOV & Co. was instrumental in supporting Sopharma throughout the negotiation and initiation of the deal. Our team was led by partners Yordan Naydenov, Peter Petrov, and Borislav Notovsky, whose expertise and commitment were instrumental in achieving this milestone.
Picture copy-rights: Pixabay.com